Literature DB >> 7473324

Death from phaeochromocytoma: lessons from a post-mortem survey.

J K Platts1, P J Drew, J N Harvey.   

Abstract

Despite advances in biochemical assessment and imaging, phaeochromocytoma remains a difficult diagnosis. Using the names of patients whose death certificate listed phaeochromocytoma as a cause of death, a retrospective survey of 62 deaths from phaeochromocytoma (48 benign, 14 malignant) was carried out. All deaths occurred between 1981 and 1989, so the pitfalls uncovered reflect recent practice. A substantial proportion presented with abdominal pain and vomiting, dyspnoea, left ventricular failure or hypotension rather than the classical symptoms. These presentations were more common in this autopsy series than in prospective series of consecutive patients. Diagnosis in the presence of classical symptoms was often delayed but, once it was made, elective excision was relatively safe. A personal or family history of symptoms suggesting inherited diseases associated with phaeochromocytoma was not always given due weight. Biochemical tests, particularly 24 hour urinary vanillyl mandelic acid, often gave contradictory results; the limits of their predictive power should be better appreciated. Anaesthesia and surgery in the presence of undiagnosed phaeochromocytoma was the cause of death in 16 of 62 cases. Recommendations to improve the accuracy of diagnosis are made.

Entities:  

Mesh:

Year:  1995        PMID: 7473324      PMCID: PMC5401324     

Source DB:  PubMed          Journal:  J R Coll Physicians Lond        ISSN: 0035-8819


  8 in total

1.  Hypertension in patients with pheochromocytoma.

Authors:  N N Hanna; D E Kenady
Journal:  Curr Hypertens Rep       Date:  1999-12       Impact factor: 5.369

Review 2.  Epinephrine-secreting cystic pheochromocytoma presenting with an incidental adrenal mass: a case report and a review of the literature.

Authors:  Cihangir Erem; Mustafa Kocak; Halil Onder Ersoz; Safak Ersoz; Yusuf Yucel
Journal:  Endocrine       Date:  2005-11       Impact factor: 3.633

3.  Mutation screening in a Norwegian cohort with pheochromocytoma.

Authors:  Wenche Sjursen; Henrik Halvorsen; Eva Hofsli; Siri Bachke; Asa Berge; Lars F Engebretsen; Sture E Falkmer; Ursula G Falkmer; Jan E Varhaug
Journal:  Fam Cancer       Date:  2013-09       Impact factor: 2.375

Review 4.  Molecular imaging and theranostic approaches in pheochromocytoma and paraganglioma.

Authors:  David Taïeb; Karel Pacak
Journal:  Cell Tissue Res       Date:  2018-02-15       Impact factor: 5.249

Review 5.  Metabologenomics of Phaeochromocytoma and Paraganglioma: An Integrated Approach for Personalised Biochemical and Genetic Testing.

Authors:  Graeme Eisenhofer; Barbara Klink; Susan Richter; Jacques Wm Lenders; Mercedes Robledo
Journal:  Clin Biochem Rev       Date:  2017-04

6.  [Intraoperative fortuitous discovery of pheochromocytoma].

Authors:  Hicham Hachlaf; Abdelhamid Madani
Journal:  Pan Afr Med J       Date:  2018-03-05

Review 7.  Paragangliomas/Pheochromocytomas: clinically oriented genetic testing.

Authors:  Rute Martins; Maria João Bugalho
Journal:  Int J Endocrinol       Date:  2014-05-12       Impact factor: 3.257

8.  A Rare Case Report of Extra-adrenal Pheochromocytoma with Normal Blood Pressure: Is that Possible?

Authors:  Ahmed Elkheshen; Masud Billah; Amir Shahbaz; Paria Zarghamravanbakhsh; Usman Nabi; Issac Sachmechi
Journal:  Cureus       Date:  2018-08-20
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.